Avalo Therapeutics, Inc.

AVTXNasdaq· Pharmaceutical Preparations

Price History

Revenue

$441,000

▼ 77.1% YoY

Net Income

-$35.1M

▼ 11.4% YoY

EPS

$-20.91

▲ 81.6% YoY

Cash

$134.5M

▲ 1714.5% YoY

FY 2024 · As of 2024-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.